Suicide Risk and Resilience in Stock Market Investors and Traders: Clinical and Medico-Legal Considerations
Behavioral Sciences · 30.04.2026 · 16 (5) · 689
DOI: 10.3390/bs16050689 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Behavioral Sciences, online erschienen am 30.04.2026. Verfasst von Leo Sher. Beteiligte Einrichtung: Department of Mental Health, U.S. Department of Veterans Affairs James J. Peters Medical Center, 130 West Kingsbridge Road, New York, NY 10468, USA. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Stock market investors and traders operate in high-pressure environments marked by volatility, uncertainty, financial risk, and intense performance demands. These conditions lead to substantial psychological distress, increasing vulnerability to psychiatric disorders and suicidal behavior. Key psychological risk factors in this population include acute financial loss, chronic stress, impulsivity, perfectionism, and identity fusion with professional performance. Evidence from behavioral psychology and clinical psychiatry indicates elevated rates of mood disorders, anxiety, and burnout in trading environments. Resilience—including emotional regulation, effective stress-coping mechanisms, strong social support, and cognitive flexibility—emerges as a critical protective factor that mitigates suicide risk and promotes adaptive functioning. Strengthening psychological resilience and implementing evidence-based mental-health strategies may help reduce suicide risk and support overall well-being. The medico-legal dimensions of this issue encompass duty of care within high-stress financial workplaces, clinical obligations related to suicide risk assessment and documentation, confidentiality and safety considerations, and questions of foreseeability of suicide in cases involving severe or catastrophic financial loss. Despite growing awareness of mental health challenges in financial professions, the intersection of suicide risk, resilience, and medico-legal responsibilities in this population remains underexplored. Further research is needed to refine assessment frameworks and develop targeted suicide prevention interventions for this at-risk group.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Mental Health, U.S. Department of Veterans Affairs James J. Peters Medical Center, 130 West Kingsbridge Road, New York, NY 10468, USA.
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons, New York, NY 10032, USA.
ORCID-Profile: Leo Sher
Zitieren
APA
Sher, L. (2026). Suicide Risk and Resilience in Stock Market Investors and Traders: Clinical and Medico-Legal Considerations. Behavioral Sciences, 16(5), 689. https://doi.org/10.3390/bs16050689
Vancouver
Sher L. Suicide Risk and Resilience in Stock Market Investors and Traders: Clinical and Medico-Legal Considerations. Behavioral Sciences. 2026;16(5):689. doi:10.3390/bs16050689
BibTeX
@article{Sher2026,
author = {Sher, Leo},
title = {Suicide Risk and Resilience in Stock Market Investors and Traders: Clinical and Medico-Legal Considerations},
journal = {Behavioral Sciences},
year = {2026},
volume = {16},
number = {5},
pages = {689},
doi = {10.3390/bs16050689}
}
EUVIMED